OBJECTIVE: Patients diagnosed with a psychotic disorder and their first-degree relatives display increased reactivity to stress. Theory predicts that experience of psychosocial stress is associated both with ventromedial prefrontal and mesolimbic dopamine neurotransmission. However, while there is evidence of aberrant striatal dopamine processing in psychotic disorder, the role of the prefrontal cortex remains under-researched. This study aimed at investigating stress-induced in vivo dopamine release in ventromedial prefrontal cortex (vmPFC) of individuals at familial risk for psychosis. METHOD: Fourteen healthy first-degree relatives of patients with a diagnosis of psychotic disorder and 10 control subjects underwent a single dynamic positron emission tomography (PET) scanning session after intravenous administration of 183.2 (SD = 7.6) MBq [(18)F]fallypride. Psychosocial stress was initiated at 100 min postinjection using a computerized mental arithmetic task with social evaluative threat components. PET data were analyzed using the linearized simplified reference region model. Regression analyses were performed to compare the spatial extent of task-related ligand displacement between control subjects and relatives and to find how it related to self-rated experiences of psychosocial stress and psychosis. RESULTS: First-degree relatives displayed hyporeactive dopamine signaling in the vmPFC in response to stress. Increased levels of subjectively rated stress were associated with increased intensity of psychotic experiences. This effect was particularly pronounced in first-degree relatives. CONCLUSION: Although previous studies have hypothesized a role for prefrontal dopamine dysfunction in psychosis, this study, to our knowledge, is the first in vivo human imaging study showing attenuated (ie, hyporeactive) dopamine stress neuromodulation in vmPFC of individuals at familial risk for psychosis.
OBJECTIVE:Patients diagnosed with a psychotic disorder and their first-degree relatives display increased reactivity to stress. Theory predicts that experience of psychosocial stress is associated both with ventromedial prefrontal and mesolimbic dopamine neurotransmission. However, while there is evidence of aberrant striatal dopamine processing in psychotic disorder, the role of the prefrontal cortex remains under-researched. This study aimed at investigating stress-induced in vivo dopamine release in ventromedial prefrontal cortex (vmPFC) of individuals at familial risk for psychosis. METHOD: Fourteen healthy first-degree relatives of patients with a diagnosis of psychotic disorder and 10 control subjects underwent a single dynamic positron emission tomography (PET) scanning session after intravenous administration of 183.2 (SD = 7.6) MBq [(18)F]fallypride. Psychosocial stress was initiated at 100 min postinjection using a computerized mental arithmetic task with social evaluative threat components. PET data were analyzed using the linearized simplified reference region model. Regression analyses were performed to compare the spatial extent of task-related ligand displacement between control subjects and relatives and to find how it related to self-rated experiences of psychosocial stress and psychosis. RESULTS: First-degree relatives displayed hyporeactive dopamine signaling in the vmPFC in response to stress. Increased levels of subjectively rated stress were associated with increased intensity of psychotic experiences. This effect was particularly pronounced in first-degree relatives. CONCLUSION: Although previous studies have hypothesized a role for prefrontal dopamine dysfunction in psychosis, this study, to our knowledge, is the first in vivo human imaging study showing attenuated (ie, hyporeactive) dopamine stress neuromodulation in vmPFC of individuals at familial risk for psychosis.
Authors: Jogeshwar Mukherjee; Bradley T Christian; Kelly A Dunigan; Bingzhi Shi; Tanjore K Narayanan; Martin Satter; Joseph Mantil Journal: Synapse Date: 2002-12-01 Impact factor: 2.562
Authors: N C Stefanis; M Hanssen; N K Smirnis; D A Avramopoulos; I K Evdokimidis; C N Stefanis; H Verdoux; J Van Os Journal: Psychol Med Date: 2002-02 Impact factor: 7.723
Authors: Christin Schifani; Sina Hafizi; Huai-Hsuan Tseng; Cory Gerritsen; Miran Kenk; Alan A Wilson; Sylvain Houle; Pablo M Rusjan; Romina Mizrahi Journal: Schizophr Res Date: 2018-11-06 Impact factor: 4.939
Authors: Michele S Milella; Aryandokht Fotros; Paul Gravel; Kevin F Casey; Kevin Larcher; Jeroen A J Verhaeghe; Sylvia M L Cox; Andrew J Reader; Alain Dagher; Chawki Benkelfat; Marco Leyton Journal: J Psychiatry Neurosci Date: 2016-08 Impact factor: 6.186
Authors: Megan Quarmley; Ruben C Gur; Bruce I Turetsky; Anna J Watters; Warren B Bilker; Mark A Elliott; Monica E Calkins; Christian G Kohler; Kosha Ruparel; Petra Rupert; Raquel E Gur; Daniel H Wolf Journal: Neuropsychopharmacology Date: 2019-05-21 Impact factor: 7.853
Authors: Dennis Hernaus; Dina Collip; Johan Lataster; Jenny Ceccarini; Gunther Kenis; Linda Booij; Jens Pruessner; Koen Van Laere; Ruud van Winkel; Jim van Os; Inez Myin-Germeys Journal: PLoS One Date: 2013-06-14 Impact factor: 3.240
Authors: D Hernaus; D Collip; Z Kasanova; O Winz; A Heinzel; T van Amelsvoort; S M Shali; J Booij; Y Rong; M Piel; J Pruessner; F M Mottaghy; I Myin-Germeys Journal: Transl Psychiatry Date: 2015-04-14 Impact factor: 6.222